Immobilized Vanadium Histidine and Tryptophan Schiff Base Complexes on Modified Magnetite Nanoparticles as Epoxidation Catalyst

In this study, magnetically recoverable vanadium complexs designated as VO(Sal-Tryp)/AmpSCMNPs and VO(Sal-His)/AmpSCMNPs were prepared through immobilization of Schiff bases of histidine or tryptophan with salicylaldehyde on the surface of modified silica coated iron oxide magnetite nanoparticles with (3-aminopropyl) trimethoxysilane as aminopropyl (Amp) spacer followed by complexation with VOSO₄. Characterization was carried out by chemical analysis, Fourier transform infrared spectroscopy, XRD, scanning electron microscopy and vibrating sample magnetometry techniques. VO(Sal-Tryp)/AmpSCMNPs and VO(Sal-His)/AmpSCMNP were found to catalyze the epoxidation of allyl alcohols and olefins with tert-butyl hydroperoxide with excellent conversions and selectivities. Investigation of the stability and reusability revealed the heterogeneity character of the catalyst with no desorption during the course of epoxidation reactions. High yields, clean reactions, easily catalyst separation and recyclability of the solid catalyst are some advantages of this method.     

Synthesis of a new schiff base oxovanadium complex with melamine and 2‐hydroxynaphtaldehyde on modified magnetic nanoparticles as catalyst for allyl alcohols and olefins epoxidation

A new magnetically recoverable nanocatalyst designated as Fe₃O₄@SiO₂@PTMS@Mel‐Naph‐VOcomplex was synthesize by covalent binding of a Schiff base ligand derived from melamine and 2‐hydroxy1naphtaldehyde on the surface of silica coated iron oxide magnetic nanoparticles followed by complexation with VO (acac)₂. Characterization of the prepared nanocatalyst was accomplished with FT‐IR, XRD, SEM, HRTEM, VSM and atomic absorption techniques. It was found that the epoxidation of geraniol, trans‐2‐hexen‐1‐ol, 1‐octen‐3‐ol, norbornene, and cyclooctene is highly selective, affording quantitative yields of the corresponding epoxides with tert‐butyl hydroperoxide (TBHP) using Fe₃O₄@SiO₂@Mel‐Naph‐VOcomplex as catalyst. High reaction yields, short reaction times, simple experimental and work up procedure, catalyst stability and excellent reusability even after five‐cycles of usage in the case of geraniol are some advantages of this research.     

Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations

Angiotensin-(1-7) re-balance the Renin-Angiotensin system affected during several pathologies, including the new COVID-19; cardiovascular diseases; and cancer. However, one of the limiting factors for its therapeutic use is its short half-life, which might be overcome with the use of dendrimers as nanoprotectors. In this work, we addressed the following issues: (1) the capacity of our computational protocol to reproduce the experimental structural features of the (hydroxyl/amino)-terminated PAMAM dendrimers as well as the Angiotensin-(1-7) peptide; (2) the coupling of Angiotensin-(1-7) to (hydroxyl/amino)-terminated PAMAM dendrimers in order to gain insight into the structural basis of its molecular binding; (3) the capacity of the dendrimers to protect Angiotensin-(1-7); and (4) the effect of pH changes on the peptide binding and covering. Our Molecular-Dynamics/Metadynamics-based computational protocol well modeled the structural experimental features reported in the literature and our double-docking approach was able to provide reasonable initial structures for stable complexes. At neutral pH, PAMAM dendrimers with both terminal types were able to interact stably with 3 Angiotensin-(1-7) peptides through ASP1, TYR4 and PRO7 key amino acids. In general, they bind on the surface in the case of the hydroxyl-terminated compact dendrimer and in the internal zone in the case of the amino-terminated open dendrimer. At acidic pH, PAMAM dendrimers with both terminal groups are still able to interact with peptides either internalized or in its periphery, however, the number of contacts, the percentage of coverage and the number of hydrogen bonds are lesser than at neutral pH, suggesting a state for peptide release. In summary, amino-terminated PAMAM dendrimer showed slightly better features to bind, load and protect Angiotensin-(1-7) peptides.